retatrutide weight loss phase 2 trial VisualAbstract: reduces body by 17.5% in patients with obesity Retatrutide: A Promising Option for

The Ala substitution at E364 6.53b caused a 58-fold reduction in affinity with a 15-fold reduced potency (Coopman et al., 2011), whereas the individual substitutions of E364 6.53b with Tyr, Asp, or Gln did not affect GLP-1 affinity or potency (Yang et al., 2016)

Your Affinity Medical Provider determines if you qualify for a treatment program, explains treatment options, potential side effects, and answers your medical questions

Several states have maintained or reinstated in-person exam requirements for controlled substances, while others have specific obesity treatment regulations regardless of modality

doi:10.1016/j.pneurobio.2010.07.003 121

Steatosis was improved in nine patients (39%) receiving liraglutide compared to two patients (9%) receiving placebo

Supports Mental Clarity: Increases in endorphins can enhance mental clarity and cognitive function